Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis
Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis
复制标题
丹参酮 IIA 保护新生大鼠心肌细胞免受阿霉素诱导的细胞凋亡
DOI:
10.1016/j.trs1.2007.11.005
复制
发表时间:
2008-02-01
影响因子:
7.8
通讯作者:
Liu, Peiqing
中科院分区:
文献类型:
--
作者:
Gao, Jie;Yang, Guoqing;Liu, Peiqing
Tanshinone IIA (TSN) is a monomer extracted from the Chinese herb Danshen. In this study, we examined the effect of Tanshinone IIA on adriamycin (ADR)-induced apoptosis in neonatal rat cardiomyocytes and underlying molecular mechanisms. Primary cultured cardiomyocytes were treated with 1 mu mol/L of adriamycin for 24 h with or without pretreatment with Tanshinone IIA (0.5-2 mu mol/L) for 2 h. 3-(4,5-dimethyl thiazol-2yl)-2,5-diphenyltetrazolium bromide (MTT) assay, Hoechst staining, and flow cytometry measurement were used to assess cell viability and apoptosis. Fluorescent probes 2',7'-dichlorofluorescein diacetate and dihydroethidium were used to detect the production of reactive oxygen species. Western blotting was used to evaluate the expression of Bcl-2 and Bax proteins. Adriamycin significantly induced apoptosis in cardiomyocytes. Tanshinone IIA (0.5-2 mu mol/L) ameliorated apoptosis induced by adriamycin in a dose-dependent manner. Tanshinone IIA (2 mu mol/L) markedly attenuated adriamycin-induced reactive oxygen species production. Western blotting revealed that Tanshinone IIA prevented the adriamycin-mediated reduction of the ratio of Bcl-2/Bax. In conclusion, Tanshinone IIA significantly inhibits adriamycin-induced cardiomyocyte apoptosis in a dose-dependent manner, and this effect is at least partly caused by its antioxidant properties.